Trials / Completed
CompletedNCT03369613
Transcranial Electrical Stimulation for Cervical Dystonia
Transcranial Electrical Stimulation (tES) for the Treatment of Cervical Dystonia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- University of Colorado, Denver · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
There are two phases. Phase I: A single visit which includes a screening, clinical scales, and a MRI scan with simultaneous tES/sham tES in a randomized block design. Enrolls both Cervical Dystonia (CD) patients and healthy controls. Phase II: 5 consecutive days of 30-90 min visits to campus for tES or sham tES. Transcranial magnetic stimulation (TMS) measures and clinical scales will also be included on Day 1 and Day 5 visits. Enrolls only CD patients.
Detailed description
Phase I: Enrolls both CD patients and healthy controls. One approximately 3 hour visit which includes: * a screening \& neurological exam, * clinical scales \& questionnaires, * a (approx.) 60 min MRI scan with simultaneous tES/sham tES in a randomized block design and EMG Phase II: Enrolls only CD patients. Five consecutive days of study visits. Day 1: * TMS screening, * repeated neurological assessment and clinical scales if \>1 month since MRI visit * 30 min TMS session with concurrent EMG * 20 min tES or sham tES session Days 2-4: \- 20 min tES or sham tES session Day 5: * 20 min tES or sham tES session * 30 min TMS session with concurrent EMG * repeated neurological assessment and clinical scales
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | transcranial electrical stimulation | The device is a Neoprene headcap that holds an array of padded electrodes close to the scalp to stimulate the underlying brain. |
Timeline
- Start date
- 2017-10-27
- Primary completion
- 2021-09-20
- Completion
- 2021-09-20
- First posted
- 2017-12-12
- Last updated
- 2022-04-25
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03369613. Inclusion in this directory is not an endorsement.